Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 May 25;14:2367–2379. doi: 10.2147/DMSO.S307776

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Zhao et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Evaluation of the prediction effect of the nomogram in the derivation (A and C) and validation (B and D) cohorts. (A and B) The pooled AUC of the ROC curve. The x-axis is the false positive rate of the risk prediction. The blue line represents the performance of the nomogram. The y-axis is the true positive rate of the risk prediction. (C and D) Decision curve analysis for the nomogram for predicting AKD risk in the AKI cohort. The x-axis is the probability. The y-axis measures the net benefit. The blue solid line is from the prediction model. The gray line represents the assumption that all AKI patients will develop into patients with AKD. The black line represents the assumption that no patients will develop into patients with AKD.